招股書(shū)顯示,翰思艾泰是一家擁有結(jié)構(gòu)生物學(xué)、轉(zhuǎn)化醫(yī)學(xué)及臨床開(kāi)發(fā)方面自主專(zhuān)業(yè)技術(shù)及經(jīng)驗(yàn)的創(chuàng)新生物科技公司,致力開(kāi)發(fā)新一代免疫療法。報(bào)告期內(nèi),該公司一直處于虧損狀態(tài),...
特別聲明:以上內(nèi)容(如有圖片或視頻亦包括在內(nèi))為自媒體平臺(tái)“網(wǎng)易號(hào)”用戶(hù)上傳并發(fā)布,本平臺(tái)僅提供信息存儲(chǔ)服務(wù)。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.